Wednesday, September 20, 2017
 

 
 
DUBLIN, September 20, 2017 /PRNewswire/ --   [READ MORE]
 
HONOLULU, Sept. 19, 2017 /PRNewswire/ -- Cardax, Inc. (OTCQB:CDXI) welcomes the findings of a clinical study recently published in the New England Journal of Medicine that validate the crucial role inflammation plays in cardiovascular health. The 10,000 patient, double-blind, placebo-controlled study ("CANTOS") sponsor.....   [READ MORE]
 
HONOLULU, Sept. 19, 2017 /PRNewswire/ -- Cardax, Inc. (OTCQB:CDXI) welcomes the findings of a clinical study recently published in the New England Journal of Medicine that validate the crucial role inflammation plays in cardiovascular health. The 10,000 patient, double-blind, placebo-controlled study ("CANTOS") sponsor.....   [READ MORE]
 
SEATTLE, Sept. 19, 2017 /PRNewswire/ -- Bulletproof 360, Inc., creators of Bulletproof® coffee and other high-performance food and nutrition products, announced today the location and details for the fifth annual Bulletproof Biohacking Conference. The th.....   [READ MORE]
 
 
MORE NEWS
 
 
 
 
 
 
 
 
 
 
 
 
 





About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines